COVID-19大流行期间肺癌的管理

2020-05-14 美国临床肿瘤学会 JCO Oncol Pract . 2020 May 26;OP2000286. doi: 10.1200/OP.20.00286

2019年冠状病毒病(COVID-19)在全球范围内产生了毁灭性影响。由于传播率高且尚无治愈性疗法或疫苗可用,当前的管理基石集中在通过社会隔离来预防。这包括减少患者的医疗保健联系。肺癌患者是特别脆弱的

中文标题:

COVID-19大流行期间肺癌的管理

英文标题:

Management of Lung Cancer During the COVID-19 Pandemic

发布机构:

美国临床肿瘤学会

发布日期:

2020-05-14

简要介绍:

2019年冠状病毒病(COVID-19)在全球范围内产生了毁灭性影响。由于传播率高且尚无治愈性疗法或疫苗可用,当前的管理基石集中在通过社会隔离来预防。这包括减少患者的医疗保健联系。肺癌患者是特别脆弱的人群,在这里,因癌症死亡的风险必须通过威胁生命的感染的潜在风险加以平衡。在这些空前的时代,需要一种协作和多学科的方法来简化但不影响护理。我们已经在学术癌症中心制定了指南,以规范整个医疗保健系统中肺癌患者的治疗,并为更大的肿瘤学界提供指导。我们建议在大多数情况下延误肺癌会导致快速的癌症进展,继续遵循肺癌的一般治疗原则。我们认识到,根据临床资源和COVID-19大流行的不断发展的性质,我们的建议可能会随着时间而改变。但是,原则上,治疗范例必须继续个体化,并仔细考虑继续或更改肺癌指导治疗的风险和益处。

相关资料下载:
[AttachmentFileName(sort=1, fileName=66.pdf)] GetToolGuiderByIdResponse(projectId=1, id=f2bd11c001966808, title=COVID-19大流行期间肺癌的管理, enTitle=Management of Lung Cancer During the COVID-19 Pandemic, guiderFrom=JCO Oncol Pract . 2020 May 26;OP2000286. doi: 10.1200/OP.20.00286, authorId=0, author=, summary=2019年冠状病毒病(COVID-19)在全球范围内产生了毁灭性影响。由于传播率高且尚无治愈性疗法或疫苗可用,当前的管理基石集中在通过社会隔离来预防。这包括减少患者的医疗保健联系。肺癌患者是特别脆弱的, cover=, journalId=0, articlesId=null, associationId=8, associationName=美国临床肿瘤学会, associationIntro=美国临床肿瘤学会(ASCO,American Society of Clinical Oncology)是一个成立于1964年的非营利性组织,总目标是改善肿瘤的监护与预防。目前已有27000名肿瘤科医师加入了ASCO,分属各个肿瘤专科和亚专科。会员包括在肿瘤治疗各个层次的医师和卫生保健专业人员。ASCO由一个有19名成员的当选董事会管理,该学会的大部分业务是由志愿为学会项目花费时间和出力的ASCO会员组成的各种委员会处理的。患者支持团体的领导也经常活跃于ASCO委员会中。目前有22个由ASCO的全职人员管理和支持的委员会。, copyright=0, guiderPublishedTime=Thu May 14 00:00:00 CST 2020, originalUrl=, linkOutUrl=, content=<p>2019年冠状病毒病(COVID-19)在全球范围内产生了毁灭性影响。由于传播率高且尚无治愈性疗法或疫苗可用,当前的管理基石集中在通过社会隔离来预防。这包括减少患者的医疗保健联系。肺癌患者是特别脆弱的人群,在这里,因癌症死亡的风险必须通过威胁生命的感染的潜在风险加以平衡。在这些空前的时代,需要一种协作和多学科的方法来简化但不影响护理。我们已经在学术癌症中心制定了指南,以规范整个医疗保健系统中肺癌患者的治疗,并为更大的肿瘤学界提供指导。我们建议在大多数情况下延误肺癌会导致快速的癌症进展,继续遵循肺癌的一般治疗原则。我们认识到,根据临床资源和COVID-19大流行的不断发展的性质,我们的建议可能会随着时间而改变。但是,原则上,治疗范例必须继续个体化,并仔细考虑继续或更改肺癌指导治疗的风险和益处。</p>, tagList=[TagDto(tagId=428, tagName=肺癌)], categoryList=[CategoryDto(categoryId=5, categoryName=肿瘤科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=20620, categoryName=肿瘤医学网, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=0, guiderKeyword=, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=1, guiderRegion=1, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=1747, appHits=67, showAppHits=0, pcHits=417, showPcHits=1680, likes=0, shares=5, comments=10, approvalStatus=1, publishedTime=Wed Sep 09 08:45:06 CST 2020, publishedTimeString=2020-05-14, pcVisible=1, appVisible=1, editorId=4754896, editor=fbzhang, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=fbzhang, createdTime=Wed Sep 09 08:45:01 CST 2020, updatedBy=4754896, updatedName=fbzhang, updatedTime=Tue Jan 02 21:40:49 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=66.pdf)])
66.pdf
下载请点击:
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=949716, encodeId=3f07949e16dc, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=82c35471352, createdName=kqch1881, createdTime=Sat Mar 20 15:20:34 CST 2021, time=2021-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=902112, encodeId=ff5390211251, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKj1Mo1VnTZ4wxFFcwh6RcnbDibOiboQVMfCthUBicyYBY030PBhQiboE0pftbkQvxV0IbAaIvyNoCTIw/132, createdBy=76da2468967, createdName=ms5000968347304471, createdTime=Wed Nov 25 11:42:17 CST 2020, time=2020-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=902111, encodeId=86cf902111a1, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKj1Mo1VnTZ4wxFFcwh6RcnbDibOiboQVMfCthUBicyYBY030PBhQiboE0pftbkQvxV0IbAaIvyNoCTIw/132, createdBy=76da2468967, createdName=ms5000968347304471, createdTime=Wed Nov 25 11:42:14 CST 2020, time=2020-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=902110, encodeId=fcce90211052, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKj1Mo1VnTZ4wxFFcwh6RcnbDibOiboQVMfCthUBicyYBY030PBhQiboE0pftbkQvxV0IbAaIvyNoCTIw/132, createdBy=76da2468967, createdName=ms5000968347304471, createdTime=Wed Nov 25 11:42:08 CST 2020, time=2020-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=895176, encodeId=8c878951e646, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/04/13/bce116f3143d02835c5907e0ad2b13a1.jpg, createdBy=a9551679187, createdName=kenblue, createdTime=Wed Oct 28 21:01:09 CST 2020, time=2020-10-28, status=1, ipAttribution=)]
    2021-03-20 kqch1881

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=949716, encodeId=3f07949e16dc, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=82c35471352, createdName=kqch1881, createdTime=Sat Mar 20 15:20:34 CST 2021, time=2021-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=902112, encodeId=ff5390211251, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKj1Mo1VnTZ4wxFFcwh6RcnbDibOiboQVMfCthUBicyYBY030PBhQiboE0pftbkQvxV0IbAaIvyNoCTIw/132, createdBy=76da2468967, createdName=ms5000968347304471, createdTime=Wed Nov 25 11:42:17 CST 2020, time=2020-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=902111, encodeId=86cf902111a1, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKj1Mo1VnTZ4wxFFcwh6RcnbDibOiboQVMfCthUBicyYBY030PBhQiboE0pftbkQvxV0IbAaIvyNoCTIw/132, createdBy=76da2468967, createdName=ms5000968347304471, createdTime=Wed Nov 25 11:42:14 CST 2020, time=2020-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=902110, encodeId=fcce90211052, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKj1Mo1VnTZ4wxFFcwh6RcnbDibOiboQVMfCthUBicyYBY030PBhQiboE0pftbkQvxV0IbAaIvyNoCTIw/132, createdBy=76da2468967, createdName=ms5000968347304471, createdTime=Wed Nov 25 11:42:08 CST 2020, time=2020-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=895176, encodeId=8c878951e646, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/04/13/bce116f3143d02835c5907e0ad2b13a1.jpg, createdBy=a9551679187, createdName=kenblue, createdTime=Wed Oct 28 21:01:09 CST 2020, time=2020-10-28, status=1, ipAttribution=)]
    2020-11-25 ms5000968347304471

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=949716, encodeId=3f07949e16dc, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=82c35471352, createdName=kqch1881, createdTime=Sat Mar 20 15:20:34 CST 2021, time=2021-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=902112, encodeId=ff5390211251, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKj1Mo1VnTZ4wxFFcwh6RcnbDibOiboQVMfCthUBicyYBY030PBhQiboE0pftbkQvxV0IbAaIvyNoCTIw/132, createdBy=76da2468967, createdName=ms5000968347304471, createdTime=Wed Nov 25 11:42:17 CST 2020, time=2020-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=902111, encodeId=86cf902111a1, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKj1Mo1VnTZ4wxFFcwh6RcnbDibOiboQVMfCthUBicyYBY030PBhQiboE0pftbkQvxV0IbAaIvyNoCTIw/132, createdBy=76da2468967, createdName=ms5000968347304471, createdTime=Wed Nov 25 11:42:14 CST 2020, time=2020-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=902110, encodeId=fcce90211052, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKj1Mo1VnTZ4wxFFcwh6RcnbDibOiboQVMfCthUBicyYBY030PBhQiboE0pftbkQvxV0IbAaIvyNoCTIw/132, createdBy=76da2468967, createdName=ms5000968347304471, createdTime=Wed Nov 25 11:42:08 CST 2020, time=2020-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=895176, encodeId=8c878951e646, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/04/13/bce116f3143d02835c5907e0ad2b13a1.jpg, createdBy=a9551679187, createdName=kenblue, createdTime=Wed Oct 28 21:01:09 CST 2020, time=2020-10-28, status=1, ipAttribution=)]
    2020-11-25 ms5000968347304471

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=949716, encodeId=3f07949e16dc, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=82c35471352, createdName=kqch1881, createdTime=Sat Mar 20 15:20:34 CST 2021, time=2021-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=902112, encodeId=ff5390211251, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKj1Mo1VnTZ4wxFFcwh6RcnbDibOiboQVMfCthUBicyYBY030PBhQiboE0pftbkQvxV0IbAaIvyNoCTIw/132, createdBy=76da2468967, createdName=ms5000968347304471, createdTime=Wed Nov 25 11:42:17 CST 2020, time=2020-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=902111, encodeId=86cf902111a1, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKj1Mo1VnTZ4wxFFcwh6RcnbDibOiboQVMfCthUBicyYBY030PBhQiboE0pftbkQvxV0IbAaIvyNoCTIw/132, createdBy=76da2468967, createdName=ms5000968347304471, createdTime=Wed Nov 25 11:42:14 CST 2020, time=2020-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=902110, encodeId=fcce90211052, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKj1Mo1VnTZ4wxFFcwh6RcnbDibOiboQVMfCthUBicyYBY030PBhQiboE0pftbkQvxV0IbAaIvyNoCTIw/132, createdBy=76da2468967, createdName=ms5000968347304471, createdTime=Wed Nov 25 11:42:08 CST 2020, time=2020-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=895176, encodeId=8c878951e646, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/04/13/bce116f3143d02835c5907e0ad2b13a1.jpg, createdBy=a9551679187, createdName=kenblue, createdTime=Wed Oct 28 21:01:09 CST 2020, time=2020-10-28, status=1, ipAttribution=)]
    2020-11-25 ms5000968347304471

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=949716, encodeId=3f07949e16dc, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=82c35471352, createdName=kqch1881, createdTime=Sat Mar 20 15:20:34 CST 2021, time=2021-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=902112, encodeId=ff5390211251, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKj1Mo1VnTZ4wxFFcwh6RcnbDibOiboQVMfCthUBicyYBY030PBhQiboE0pftbkQvxV0IbAaIvyNoCTIw/132, createdBy=76da2468967, createdName=ms5000968347304471, createdTime=Wed Nov 25 11:42:17 CST 2020, time=2020-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=902111, encodeId=86cf902111a1, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKj1Mo1VnTZ4wxFFcwh6RcnbDibOiboQVMfCthUBicyYBY030PBhQiboE0pftbkQvxV0IbAaIvyNoCTIw/132, createdBy=76da2468967, createdName=ms5000968347304471, createdTime=Wed Nov 25 11:42:14 CST 2020, time=2020-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=902110, encodeId=fcce90211052, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKj1Mo1VnTZ4wxFFcwh6RcnbDibOiboQVMfCthUBicyYBY030PBhQiboE0pftbkQvxV0IbAaIvyNoCTIw/132, createdBy=76da2468967, createdName=ms5000968347304471, createdTime=Wed Nov 25 11:42:08 CST 2020, time=2020-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=895176, encodeId=8c878951e646, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/04/13/bce116f3143d02835c5907e0ad2b13a1.jpg, createdBy=a9551679187, createdName=kenblue, createdTime=Wed Oct 28 21:01:09 CST 2020, time=2020-10-28, status=1, ipAttribution=)]
    2020-10-28 kenblue

    学习学习

    0